
Novartis: Chasing Revenue Might Lose Sight Of Medicine (NYSE:NVS)
yuelan/iStock Editorial via Getty Images It is not often that one gets a frank insight into the new broad strategic direction of a big pharma company, but Novartis (NYSE:NVS) has done just that recently. It […]